This is a Phase II, single arm, multi-center trial, designed to estimate the efficacy and toxicity of haploidentical bone marrow transplantation (BMT) in patients with sickle cell disease (SCD). Based on their age and entry criteria patients are…
- Investigator
- John A Fort
- Status
- Accepting Candidates
- Ages
- 5 Years - 45 Years
- Sexes
- All